Beigene Stock Market Capitalization
| 688235 Stock | 176.00 0.32 0.18% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
BeiGene |
BeiGene Company Market Capitalization Analysis
BeiGene's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current BeiGene Market Capitalization | 164.41 B |
Most of BeiGene's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BeiGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of BeiGene is about 164.41 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The market capitalization for all China stocks is notably lower than that of the firm.
BeiGene Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in market capitalization category among its peers.
BeiGene Fundamentals
| Return On Equity | -0.23 | |||
| Return On Asset | -0.0958 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 152.56 B | |||
| Shares Outstanding | 115.06 M | |||
| Shares Owned By Insiders | 4.16 % | |||
| Shares Owned By Institutions | 32.72 % | |||
| Price To Book | 9.79 X | |||
| Price To Sales | 6.99 X | |||
| Revenue | 2.46 B | |||
| Gross Profit | (511.06 M) | |||
| EBITDA | (5.58 B) | |||
| Net Income | (881.71 M) | |||
| Total Debt | 688.37 M | |||
| Book Value Per Share | 226.72 X | |||
| Cash Flow From Operations | (1.16 B) | |||
| Earnings Per Share | (4.57) X | |||
| Target Price | 196.06 | |||
| Number Of Employees | 10.6 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 164.41 B | |||
| Total Asset | 5.81 B | |||
| Retained Earnings | (7.96 B) | |||
| Working Capital | 2.39 B | |||
| Net Asset | 5.81 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.